-
2025-08-29 / News
3SBio Announces 2025 Interim Results: Value Realization of Innovative Achievements and Strong Long-Term Growth Momentum
-
2025-03-25 / News
3SBio Unveils 2024 Annual Results: Profit Surges 34.9% YoY, Innovation Pipeline Delivers Strong Value
-
2024-08-22 / News
3SBio Unveils 2024 Interim Results: Revenue Up 16% YoY, Autoimmune Pipeline Poised for a Promising Phase
-
2024-03-20 / News
3SBio reveals 2023 annual results: Revenue surges by 13.8% year on year, with pipelines to reap the rewards
3SBio will remain steadfast in its role as a national biopharmaceutical leader
-
2023-03-21 / News
3SBio announces 2022 annual results, with revenue rising 7.5% year on year and normalized net profit attributable to parents jumping 25.2%
3SBio is committed to sharpening its focus on refined management and ensuring the healthy developmen...
-
2022-08-24 / News
3SBio announces 2022 interim results, with net profit attributable to owners of the parents continuing to grow despite COVID-19 and cash hitting new record high
with net profit attributable to owners of the parents continuing to grow despite COVID-19 and cash h...